RT @HealthTechRmdy: New episode of @HealthTechRmdy with @enhanced @enhanced_games CEO @aronpingdsouza. This isn't just about making athlete….

RT @HealthTechRmdy: 🎙️👂 Hear how healthtech innovators @AlexDeyle and @flatironhealth are working to make the clinical research infrastruct….

RT @HealthTechRmdy: New episode of @HealthTechRmdy with @Science37x CMO Jonathan Cotliar. A fascinating discussion on decentralized clinica….

RT @tjroycemd: Listen to hear how AI is being used to discover new drug applications by through repurposing existing drugs for rare disease….

Listen to hear how AI is being used to discover new drug applications by through repurposing existing drugs for rare diseases and more.

RT @HealthTechRmdy: On this episode of @HealthTechRmdy we explore how Dr. Yousuf Zafar @yzafar and @myaccesshope are democratizing cancer….

@TimShowalter1.

🔥 new episode of @HealthTechRmdy. We hear the incredible story of @DavidFajgenbaum and @EveryCure. National best selling author who discovered a treatment to save his own life as a medical student, and now repurposing drugs for rare diseases and beyond.

RT @anirrjoshi: Excited to share our @valarlabs publication in @EUplatinum validating Vesta Risk Stratify computational histology AI biomar….

RT @valarlabs: We are pleased to share our new publication in European Urology validating Vesta Risk Stratify biomarkers for prediction of….

Cc @TimShowalter1 🎤.

In this episode we chat w ⁦@othman CEO/cofounder⁩ ⁦@Color⁩ - give us a listen for a story of impact and inspiration for how health technology can improve care delivery

“If only the therapeutic radiation PR team was up and running, there may have been mention of prostate-directed radiation as a modern non-invasive low-burden extremely well-tolerated option for a whole host of prostate cancers.”.

“with ever-evolving technological advances. And that, of course, is referring to “the main treatment for early prostate cancer—removing the tumor,” which can be done with minimally invasive surgery.”.

““the risk-benefit analysis for screening has changed in recent years,” while recognizing another crucial piece of the puzzle, namely that definitive treatment of localized disease carries less risk and long term side effects than ever before”.

“all in order to stick with political talking points de jour that—randomly, today—suit one side versus another? Thankfully, radiologist Dr. Koo is quoted stating the undeniable:”.

“Are we now ignoring the years of work developing and finessing tools to such as multiparametric prostate MRIs and individualized detailed PSA analyses to successfully slash the rate of clinically meaningless prostate biopsies,”.

Tune Out the Noise | Documentary Film via @YouTube.

"In what is believed to be the world’s first remotely-conducted, transcontinental robotic-assisted focal therapy for prostate cancer. " .🤔.

RT @UroDocAsh: Our recent publication in @EurUrolOncol demonstrates - for the first time -that an AI-powered histologic biomarker (CHAI) ca….